Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Celsion Corp (CLSN)

Celsion Corp (CLSN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 76,333
  • Shares Outstanding, K 37,418
  • Annual Sales, $ 500 K
  • Annual Income, $ -16,850 K
  • 60-Month Beta 2.18
  • Price/Sales 117.87
  • Price/Cash Flow N/A
  • Price/Book 4.17
Trade CLSN with:

Options Overview

Details
  • Implied Volatility 222.89%
  • Historical Volatility 206.84%
  • IV Percentile 8%
  • IV Rank 4.26%
  • IV High 865.77% on 10/20/20
  • IV Low 194.31% on 08/18/20
  • Put/Call Vol Ratio 0.06
  • Today's Volume 1,973
  • Volume Avg (30-Day) 6,918
  • Put/Call OI Ratio 0.23
  • Today's Open Interest 37,365
  • Open Int (30-Day) 29,553

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5500 +19.35%
on 02/05/21
3.4800 -46.84%
on 02/11/21
+0.3200 (+20.92%)
since 02/04/21
3-Month
0.5860 +215.70%
on 12/09/20
3.4800 -46.84%
on 02/11/21
+1.2355 (+201.06%)
since 12/04/20
52-Week
0.4305 +329.73%
on 11/02/20
6.5000 -71.54%
on 06/17/20
+0.7300 (+65.18%)
since 03/04/20

Most Recent Stories

More News
Poster on Celsion Corporation's Phase I/II OVATION 2 Study to be Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women's Cancer

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that a poster on the Company's Phase I/II OVATION...

CLSN : 1.8500 (-9.31%)
Celsion Corporation to Participate in the Virtual 33ʳ�? Annual Roth Conference

Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today announced that management will be holding one-on-one meetings...

CLSN : 1.8500 (-9.31%)
Celsion Corporation Provides Clinical Update on Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer Including Encouraging Interim Resection Scores

Of 27 patients who completed interval debulking surgery, 80% of those treated with GEN-1 had an R0 resection compared with 58% of control patients, a 38% improvement

CLSN : 1.8500 (-9.31%)
Celsion Receives $2 Million Allocation Through the New Jersey Technology Business Tax Certificate Transfer (NOL) Program

Non-Dilutive Funding Strengthens Balance Sheet; Extends Current Operating Runway to Over Three Years

CLSN : 1.8500 (-9.31%)
Celsion Corporation Receives FDA Fast Track Designation for GEN-1 in Advanced Ovarian Cancer

Celsion's Commitment to Promoting Immune System Solutions to Fight Life-Threatening Diseases

CLSN : 1.8500 (-9.31%)
Thinking about buying stock in Celsion Corp, Can Fite Biopharma, ConforMIS Inc, Citius Pharmaceuticals, or Vuzix Corp?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSN, CANF, CFMS, CTXR, and VUZI.

CANF : 1.8000 (-7.69%)
CFMS : 0.9200 (-15.60%)
CLSN : 1.8500 (-9.31%)
CTXR : 1.7700 (-7.81%)
VUZI : 15.62 (-22.90%)
Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CANF, CLSN, MARK, PSTV, and SNES.

CANF : 1.8000 (-7.69%)
PSTV : 2.23 (-7.08%)
CLSN : 1.8500 (-9.31%)
MARK : 2.35 (-11.99%)
SNES : 1.4900 (-12.87%)
Celsion Corporation Announces Formation of Vaccine Advisory Board

Board to provide guidance in developing the PLACCINE platform for the prevention and treatment of infectious agents, including SARS-CoV-2

CLSN : 1.8500 (-9.31%)
Thinking about buying stock in Seelos Therapeutics, Celsion Corp, Zosano Pharma, Outlook Therapeutics, or Infinity Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SEEL, CLSN, ZSAN, OTLK, and INFI.

INFI : 2.76 (-4.83%)
OTLK : 1.8100 (-9.95%)
SEEL : 2.66 (-9.83%)
CLSN : 1.8500 (-9.31%)
ZSAN : 1.0700 (-12.30%)
Celsion Corporation Issues Letter to Stockholders

Discusses Broad-based DNA Vaccine Initiative, OVATION 2 Study,

CLSN : 1.8500 (-9.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the...

See More

Key Turning Points

3rd Resistance Point 2.4233
2nd Resistance Point 2.2167
1st Resistance Point 2.0333
Last Price 1.8500
1st Support Level 1.6433
2nd Support Level 1.4367
3rd Support Level 1.2533

See More

52-Week High 6.5000
Fibonacci 61.8% 4.1815
Fibonacci 50% 3.4653
Fibonacci 38.2% 2.7490
Last Price 1.8500
52-Week Low 0.4305

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar